{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:14:25Z","timestamp":1788509665909,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104309","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:33:21Z","timestamp":1777617201000},"page":"104309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism-informed evaluation of particle formation in high-concentration monoclonal antibodies during fill\u2013finish: Impact of pump materials, surface interactions, and system architecture"],"prefix":"10.1016","volume":"115","author":[{"given":"Adam","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Fenercioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Anleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advait","family":"Badkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4449-1011","authenticated-orcid":false,"given":"Parag","family":"Kolhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2026.104309_bib0001","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jps.22276","article-title":"Impact of product-related factors on immunogenicity of biotherapeutics","volume":"100","author":"Singh","year":"2011","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104309_bib0002","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104309_bib0003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jps.22790","article-title":"Classification of protein aggregates","volume":"101","author":"Narhi","year":"2012","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104309_bib0004","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/bit.27801","article-title":"Adsorbed protein film on pump surfaces leads to particle formation during fill-finish manufacturing","volume":"118","author":"Roffi","year":"2021","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.xphs.2019.05.013","article-title":"Effects of tubing type, formulation, and postpumping agitation on nanoparticle and microparticle formation in intravenous immunoglobulin solutions processed with a peristaltic filling pump","volume":"109","author":"Her","year":"2020","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104309_bib0006","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.22812","article-title":"Forced degradation of therapeutic proteins","volume":"101","author":"Hawe","year":"2012","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104309_bib0007","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.xphs.2020.12.002","article-title":"Finding the needle in the haystack: high-resolution techniques for characterization of mixed protein particles containing shed silicone rubber particles generated during pumping","volume":"110","author":"Deiringer","year":"2021","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104309_bib0008","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11095-009-0045-6","article-title":"Stability of protein pharmaceuticals: an update","volume":"27","author":"Manning","year":"2010","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2026.104309_bib0009","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.xphs.2021.06.014","article-title":"Characterization of proteinaceous particles in monoclonal antibody drug products using mass spectrometry","volume":"110","author":"Xu","year":"2021","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104309_bib0010","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/jps.22676","article-title":"Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution","volume":"100","author":"Nayak","year":"2011","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104309_bib0011","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.copbio.2009.10.006","article-title":"Formulation and manufacturability of biologics","volume":"20","author":"Shire","year":"2009","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jps.21419","article-title":"IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles","volume":"98","author":"Tyagi","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/bit.22525","article-title":"Aggregation of a monoclonal antibody induced by adsorption to stainless steel","volume":"105","author":"Bee","year":"2010","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2026.104309_bib0014","series-title":"United States Pharmacopeia\u2013National Formulary (USP\u2013NF)","article-title":"USP <1790>visual inspection of injections","year":"2024"},{"key":"10.1016\/j.xphs.2026.104309_bib0015","series-title":"United States Pharmacopeia\u2013National Formulary (USP\u2013NF)","article-title":"USP <790>visible particulates in injections","year":"2024"},{"key":"10.1016\/j.xphs.2026.104309_bib0016","series-title":"United States Pharmacopeia\u2013National Formulary (USP\u2013NF)","article-title":"USP <787>subvisible particulate matter in injections","year":"2024"},{"issue":"7","key":"10.1016\/j.xphs.2026.104309_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103804","article-title":"Assessing the impact of viscosity lowering excipient on liquid-liquid phase separation for high concentration monoclonal antibody solutions","volume":"114","author":"Thorn","year":"2025","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104309_bib0018","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1063\/1.1716296","article-title":"Modified spin-echo method for measuring nuclear relaxation times","volume":"29","author":"Meiboom","year":"1958","journal-title":"Review of Scientific Instruments"},{"key":"10.1016\/j.xphs.2026.104309_bib0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2019.12.006","article-title":"Low volume aseptic filling: impact of pump systems on shear stress","volume":"147","author":"Dreckmann","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2026.104309_bib0020","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.xphs.2020.01.023","article-title":"Aggregation and particle formation during pumping of an antibody formulation are controlled by electrostatic interactions between pump surfaces and protein molecules","volume":"109","author":"Wu","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104309_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118636","article-title":"ATR-FTIR spectroscopy and spectroscopic imaging for the analysis of biopharmaceuticals","volume":"241","author":"Tiernan","year":"2020","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.xphs.2026.104309_bib0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.aca.2019.07.007","article-title":"Rapid, quantitative determination of aggregation and particle formation for antibody drug conjugate therapeutics with label-free Raman spectroscopy","volume":"1081","author":"Zhang","year":"2019","journal-title":"Anal Chim Acta"},{"issue":"8","key":"10.1016\/j.xphs.2026.104309_bib0023","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1021\/acs.molpharmaceut.3c00391","article-title":"Characterizing silicone oil-induced protein aggregation with stimulated raman scattering imaging","volume":"20","author":"Wong","year":"2023","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104309_bib0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antib7030024","article-title":"Engaging with Raman spectroscopy to investigate antibody aggregation","volume":"7","author":"Ettah","year":"2018","journal-title":"Antibodies (Basel)"},{"issue":"8","key":"10.1016\/j.xphs.2026.104309_bib0025","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.22097","article-title":"An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics","volume":"99","author":"Singh","year":"2010","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104309_bib0026","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10853-014-8685-2","article-title":"Performing elemental microanalysis with high accuracy and high precision by scanning electron microscopy\/silicon drift detector energy-dispersive X-ray spectrometry (SEM\/SDD-EDS)","volume":"50","author":"Newbury","year":"2015","journal-title":"J Mater Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104309_bib0027","article-title":"Characterization of titanium corrosion and its association with peri-implantitis using energy dispersive X-ray spectroscopy: a case report","volume":"16","author":"Atchuta","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2026.104309_bib0028","series-title":"United States Pharmacopeia\u2013National Formulary (USP\u2013NF)","article-title":"<788>Particulate matter in injections","year":"2012"},{"key":"10.1016\/j.xphs.2026.104309_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123679","article-title":"Shear stress as a driver of degradation for protein-based therapeutics: more accomplice than culprit","volume":"650","author":"Moino","year":"2024","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2026.104309_bib0030","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/jps.21521","article-title":"Principles, approaches, and challenges for predicting protein aggregation rates and shelf life","volume":"98","author":"WFt","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2007","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104309_bib0032","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1021\/acs.analchem.7b00464","article-title":"Water proton NMR: a tool for protein aggregation characterization","volume":"89","author":"Taraban","year":"2017","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0033","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2304624","article-title":"In-situ biophysical characterization of high-concentration protein formulations using wNMR","volume":"16","author":"Song","year":"2024","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.xphs.2026.104309_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.xphs.2018.10.002","article-title":"Holographic characterization of protein aggregates in the presence of silicone oil and surfactants","volume":"108","author":"Kasimbeg","year":"2019","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104309_bib0035","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.xphs.2020.05.002","article-title":"Quantitative differentiation of protein aggregates from other subvisible particles in viscous mixtures through holographic characterization","volume":"109","author":"Winters","year":"2020","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104309_bib0036","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1039\/D0SM02262D","article-title":"Holographic characterization and tracking of colloidal dimers in the effective-sphere approximation","volume":"17","author":"Altman","year":"2021","journal-title":"Soft Matter"},{"issue":"4","key":"10.1016\/j.xphs.2026.104309_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104196","article-title":"A novel in silico platform combining data-driven and physics-based models for protein formulation developability assessment","volume":"115","author":"Arsiccio","year":"2026","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104309_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.xphs.2022.10.009","article-title":"Surface-induced protein aggregation and particle formation in biologics: current understanding of mechanisms, detection and mitigation strategies","volume":"112","author":"Kopp","year":"2023","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104309_bib0039","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1021\/acs.molpharmaceut.7b01127","article-title":"Protein adsorption and layer formation at the stainless steel\u2013Solution interface mediates shear-induced particle formation for an IgG1 monoclonal antibody","volume":"15","author":"Kalonia","year":"2018","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.xphs.2026.104309_bib0040","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.xphs.2022.11.017","article-title":"Investigating and addressing challenges associated with filling protein drug products","volume":"112","author":"Pardeshi","year":"2023","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104309_bib0041","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/btpr.1548","article-title":"Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach","volume":"28","author":"Eon-Duval","year":"2012","journal-title":"Biotechnol Prog"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:36:19Z","timestamp":1788507379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926001589"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104309","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-informed evaluation of particle formation in high-concentration monoclonal antibodies during fill\u2013finish: Impact of pump materials, surface interactions, and system architecture","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104309"}}